Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.
D000328:Adult; D015703:Antigens, CD / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001989:Bronchiolitis Obliterans / Q000175:diagnosis*; D004646:Emphysema / Q000601:surgery; D005260:Female; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007258:Informed Consent; D017730:Ki-1 Antigen / Q000097:blood*; D016040:Lung Transplantation / Q000009:adverse effects / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011183:Postoperative Complications / Q000175:diagnosis*; D011237:Predictive Value of Tests; D029424:Pulmonary Disease, Chronic Obstructive / Q000601:surgery; D016559:Tacrolimus / Q000627:therapeutic use
D015703:Antigens, CD; D015415:Biomarkers; D007166:Immunosuppressive Agents; D017730:Ki-1 Antigen; D009173:Mycophenolic Acid; D016559:Tacrolimus